These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37919410)

  • 1. Bacteraemia caused by non-faecalis and non-faecium Enterococcus species-a retrospective study of incidence, focus of infection, and prognosis.
    Lohikoski R; Oldberg K; Rasmussen M
    Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):45-53. PubMed ID: 37919410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.
    Pinholt M; Ostergaard C; Arpi M; Bruun NE; Schønheyder HC; Gradel KO; Søgaard M; Knudsen JD;
    Clin Microbiol Infect; 2014 Feb; 20(2):145-51. PubMed ID: 23647880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia.
    Suppola JP; Kuikka A; Vaara M; Valtonen VV
    Scand J Infect Dis; 1998; 30(2):153-7. PubMed ID: 9730302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.
    McBride SJ; Upton A; Roberts SA
    Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):107-14. PubMed ID: 19916034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective observational study on enterococcal bacteraemia and endocarditis at a regional hospital in New South Wales, Australia.
    Lwin N; Bannan A
    Infect Dis Health; 2020 Nov; 25(4):245-252. PubMed ID: 32561340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia in cancer patients.
    Conde-Estévez D; Grau S; Albanell J; Terradas R; Salvadó M; Knobel H
    Eur J Clin Microbiol Infect Dis; 2011 Jan; 30(1):103-8. PubMed ID: 20711795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and outcomes associated with vancomycin-resistant Enterococcus faecium and ampicillin-resistant Enterococcus faecalis bacteraemia: A 10-year study in a tertiary-care centre in Mexico City.
    López-Luis BA; Sifuentes-Osornio J; Lambraño-Castillo D; Ortiz-Brizuela E; Ramírez-Fontes A; Tovar-Calderón YE; Leal-Vega FJ; Bobadilla-Del-Valle M; Ponce-de-León A
    J Glob Antimicrob Resist; 2021 Mar; 24():198-204. PubMed ID: 33359937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study.
    Billington EO; Phang SH; Gregson DB; Pitout JD; Ross T; Church DL; Laupland KB; Parkins MD
    Int J Infect Dis; 2014 Sep; 26():76-82. PubMed ID: 24813873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
    Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
    BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic relatedness of Enterococcus faecalis isolates with high-level gentamicin resistance from patients with bacteraemia in the south east of Sweden 1994-2001.
    Saeedi B; Hällgren A; Isaksson B; Jonasson J; Nilsson LE; Hanberger H
    Scand J Infect Dis; 2004; 36(6-7):405-9. PubMed ID: 15307558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study.
    Scharloo F; Cogliati Dezza F; López-Hernández I; Martínez Pérez-Crespo PM; Goikoetxea Aguirre AJ; Pérez-Rodríguez MT; Fernandez-Suarez J; León Jiménez E; Morán Rodríguez MÁ; Fernández-Natal I; Reguera Iglesias JM; Natera Kindelán C; Fariñas Álvares MC; Boix-Palop L; Lopez-Cortes LE; Rodríguez-Baño J;
    Eur J Clin Microbiol Infect Dis; 2024 Oct; 43(10):2011-2022. PubMed ID: 39112668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project.
    Mussa M; Martínez Pérez-Crespo PM; Lopez-Cortes LE; Retamar-Gentil P; Sousa-Dominguez A; Goikoetxea-Aguirre AJ; Reguera-Iglesias JM; León Jiménez E; Fernández-Natal I; Armiñanzas-Castillo C; Boix-Palop L; Cuquet-Pedragosa J; Morán Rodríguez MÁ; Fernandez-Suarez J; Del Arco-Jiménez A; Jóver-Saenz A; Bahamonde-Carrasco A; Galan-Sanchez F; Sánchez-Calvo JM; Smithson-Amat A; Vinuesa-García D; Sánchez-Porto A; López-Hernández I; Rodríguez-Baño J;
    Microbiol Spectr; 2022 Aug; 10(4):e0005122. PubMed ID: 35771010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterococcal bacteraemia: predictive and prognostic risk factors for ampicillin resistance.
    Matsumura T; Nagao M; Nakano S; Yamamoto M; Matsumura Y; Ichiyama S
    Epidemiol Infect; 2018 Dec; 146(16):2028-2035. PubMed ID: 30165917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of urinary tract infections caused by Enterococci: A multicenter retrospective study from two tertiary hospitals in Saudi Arabia.
    Alharthi KF; Baotob SM; Bankhar AM; Alsehli AA; Idris IA; Badawood MS; Alharbi WK; Almatrafi MM; Mahrous AJ; Thabit AK
    J Infect Chemother; 2024 Nov; 30(11):1190-1193. PubMed ID: 38942290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
    Forrest GN; Arnold RS; Gammie JS; Gilliam BL
    J Infect; 2011 Dec; 63(6):420-8. PubMed ID: 21920382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing trend in enterococcal bacteraemia and vancomycin resistance in a tertiary care hospital in Croatia, 2017-2021.
    Todorić Z; Majdandžić I; Keretić Kregar T; Herljević Z; Ćorić M; Lešin J; Kuliš T; Mareković I
    Infect Dis (Lond); 2023 Jan; 55(1):9-16. PubMed ID: 36240424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.